Digital Weight Loss Intervention for Obesity and Type 2 Diabetes Risk
(mLIFE Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial requires that you do not use medications that may impact blood glucose. If you are taking such medications, you may need to stop them to participate.
What data supports the effectiveness of the treatment mLIFE app for weight loss and diabetes risk reduction?
Research shows that mobile health apps, like the Social POD app, which focus on social support and self-monitoring, can help with weight loss by encouraging healthy behaviors. Additionally, digital tools for diabetes management have been found to improve patient engagement and outcomes by promoting self-management and motivation.12345
Is the digital weight loss intervention generally safe for humans?
How is the mLIFE app treatment for obesity and Type 2 diabetes risk different from other treatments?
The mLIFE app treatment is unique because it incorporates self-regulation and social support features to help users manage their weight and reduce the risk of Type 2 diabetes. Unlike traditional methods, this digital intervention leverages mobile health technology to enhance user engagement and support through social networks, making it a novel approach in weight management.128910
What is the purpose of this trial?
The goal of the study is to examine long term sustained weight loss digital intervention in a diverse cohort of adults with overweight/obesity. The intervention includes social gaming (using game-like elements in nongame contexts to promote supportive social interactions and openness to positive behavioral influences) to reward behaviors, such as self-monitoring and social support.Investigators will accomplish objectives and test hypotheses by following two specific primary aims:1. Determine if the intervention plus gaming produces significantly more weight loss at 12 months than the same intervention without gaming among 240 adults with overweight or obesity and ≥3 T2DM risk factors.2. Examine the differences in social support provision and receipt between groups at 12 months.
Research Team
Brie Turner-McGrievy, PhD, MS, RD
Principal Investigator
University of South Carolina
Eligibility Criteria
This trial is for adults aged 18-65 with obesity or overweight, having a BMI of 25-49.9 kg/m2 and at least three risk factors for Type 2 diabetes but not diagnosed with it. Participants must own a smartphone, be willing to change their diet and exercise habits, and not be on medications affecting blood glucose or involved in other weight loss programs.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Orientation and Baseline Assessment
Participants attend a study orientation, complete all baseline measures, and are randomized into groups
Intervention
Participants engage in a 1-year behavioral intervention using the mLIFE app, with or without gamification, including twice-weekly podcasts and daily tracking
Assessment
Participants complete assessments at 6 and 12 months to evaluate changes in weight, diet, and physical activity
Follow-up
Participants are monitored for sustained weight loss and behavioral changes after the intervention
Treatment Details
Interventions
- mLIFE app (self-regulation features)
- mLIFE app (social support features)
- Podcasts and tips of the day (within app)
- standard mLIFE app (social support features)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of South Carolina
Lead Sponsor